OLEMA ONCOLOGY
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
OLEMA ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.olema.com
Total Employee:
11+
Status:
Active
Contact:
4157428265
Email Addresses:
[email protected]
Total Funding:
145.05 M USD
Technology used in webpage:
Google Font API Font Awesome Mobile Non Scaleable Content Nginx DigiCert SSL Digital Ocean RapidSSL Nginx 1.17
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - Olema Oncology
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Olema Oncology
Deerfield
Deerfield investment in Series C - Olema Oncology
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Olema Oncology
Wellington Management
Wellington Management investment in Series C - Olema Oncology
RA Capital Management
RA Capital Management investment in Series C - Olema Oncology
Venrock
Venrock investment in Series C - Olema Oncology
BVF Partners
BVF Partners investment in Series C - Olema Oncology
Logos Capital
Logos Capital investment in Series C - Olema Oncology
Vivo Capital
Vivo Capital investment in Series C - Olema Oncology
Key Employee Changes
Date | New article |
---|---|
2022-01-31 | Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.olema.com Semrush global rank: 2.41 M Semrush visits lastest month: 7.51 K
- Host name: 107.55.224.35.bc.googleusercontent.com
- IP address: 35.224.55.107
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York